AGIO Exercise Disclosure
Gheuens Sarah · SEC Form 4 · Filed Oct 23, 2026
Exercise
Calculated transaction value
$0
Gheuens Sarah Chief Medical Officer
AGIO
Transaction date
Oct 21, 2026
Public filing date
Oct 23, 2026
Filing lag
Filed 2 days later
AGIO daily price context
Close on/before transaction
$37.18
Oct 21, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock options (right to buy) on Common stock
- Quantity / price
- 1,489 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001439222-26-000122
Filing cohort
Transactions in this filing
Showing 6 of 6
Trades
6
Issuers
1
Estimated value
$124.39K
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Agios Pharmaceuticals, Inc. AGIO | Exercise | Oct 22, 2026 | $0 |
| Agios Pharmaceuticals, Inc. AGIO | Exercise | Oct 22, 2026 | $12.51K |
| Agios Pharmaceuticals, Inc. AGIO | Sale | Oct 22, 2026 | $18.76K |
| Agios Pharmaceuticals, Inc. AGIO | Sale | Oct 21, 2026 | $55.88K |
| Agios Pharmaceuticals, Inc. AGIO | Exercise | Oct 21, 2026 | $37.24K |
| Agios Pharmaceuticals, Inc. AGIO Current | Exercise | Oct 21, 2026 | $0 |